Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Bio-Techne ( (TECH) ) just unveiled an announcement.
At its annual meeting, Bio-Techne Corporation announced the election of nine directors and the approval of executive compensation and KPMG LLP as its independent auditor for fiscal year ending June 30, 2026. The company reported a slight decrease in first-quarter fiscal 2026 revenue to $286.6 million, with a GAAP EPS increase to $0.24. The divestiture of Exosome Diagnostics and cost initiatives improved operating margins. Despite challenges in the emerging biotech sector, Bio-Techne saw stabilization in the US academic market and growth in its ProteinSimple and Spatial Biology segments. The company remains focused on its strategic growth pillars, including cell therapy, where some customers received FDA Fast Track Designation.
The most recent analyst rating on (TECH) stock is a Buy with a $73.00 price target. To see the full list of analyst forecasts on Bio-Techne stock, see the TECH Stock Forecast page.
Spark’s Take on TECH Stock
According to Spark, TipRanks’ AI Analyst, TECH is a Outperform.
Bio-Techne’s overall stock score reflects a stable financial position with strong cash flow and prudent leverage. The technical analysis shows bullish momentum, but the high P/E ratio suggests potential overvaluation. Strategic moves to enhance profitability are positive, but challenges in academia and biotech funding uncertainties remain risks.
To see Spark’s full report on TECH stock, click here.
More about Bio-Techne
Bio-Techne Corporation is a global life sciences company that provides innovative tools and bioactive reagents for research and clinical diagnostics. Their products support scientific investigations into biological processes, aid in drug discovery, and enable accurate clinical tests and diagnoses. With a broad portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and employs approximately 3,100 people worldwide.
Average Trading Volume: 2,308,039
Technical Sentiment Signal: Hold
Current Market Cap: $9.51B
See more data about TECH stock on TipRanks’ Stock Analysis page.